Sowell Financial Services LLC Revance Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$26.8 - $31.84 $2,680 - $3,184	-100 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$24.03 - $29.97 $5,478 - $6,833	-228 Reduced 69.51%	100 $3,000
Q4 2020 Jan 13, 2021	BUY	$23.41 - $28.34 $6,039 - $7,311	258 Added 368.57%	328 $9,000
Q3 2020 Nov 12, 2020	SELL	$23.23 - $34.3 $4,506 - $6,654	-194 Reduced 73.48%	70 $2,000
Q2 2020 Aug 13, 2020	BUY	$12.6 - $26.55 $3,326 - $7,009	264 New	264 $6,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.